HEADER HORMONE 10-FEB-06 2CEU TITLE DESPENTAPEPTIDE INSULIN IN ACETIC ACID (PH 2) COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: DESPENTAPEPTIDE-B26-B30 INSULIN; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: INSULIN; COMPND 8 CHAIN: B, D; COMPND 9 SYNONYM: DESPENTAPEPTIDE-B26-B30 INSULIN; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 4932; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 4932 KEYWDS INSULIN, DESPENTAPEPTIDE, ACETIC ACID, PH 2, CARBOHYDRATE KEYWDS 2 METABOLISM, DIABETES MELLITUS, DISEASE MUTATION, GLUCOSE KEYWDS 3 METABOLISM, HORMONE, PHARMACEUTICAL EXPDTA X-RAY DIFFRACTION AUTHOR J.L.WHITTINGHAM,Y.ZHANG,L.ZAKOVA,E.J.DODSON,J.P.TURKENBURG, AUTHOR 2 J.BRANGE,G.G.DODSON REVDAT 2 24-FEB-09 2CEU 1 VERSN REVDAT 1 03-MAR-06 2CEU 0 JRNL AUTH J.L.WHITTINGHAM,Z.YOUSHANG,L.ZAKOVA,E.J.DODSON, JRNL AUTH 2 J.P.TURKENBURG,J.BRANGE,G.G.DODSON JRNL TITL I222 CRYSTAL FORM OF DESPENTAPEPTIDE (B26-B30) JRNL TITL 2 INSULIN PROVIDES NEW INSIGHTS INTO THE PROPERTIES JRNL TITL 3 OF MONOMERIC INSULIN. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 62 505 2006 JRNL REFN ISSN 0907-4449 JRNL PMID 16627943 JRNL DOI 10.1107/S0907444906006871 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.13 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 8413 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 423 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.79 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.84 REMARK 3 REFLECTION IN BIN (WORKING SET) : 598 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1450 REMARK 3 BIN FREE R VALUE SET COUNT : 36 REMARK 3 BIN FREE R VALUE : 0.2150 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 774 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 15 REMARK 3 SOLVENT ATOMS : 65 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.38000 REMARK 3 B22 (A**2) : 0.15000 REMARK 3 B33 (A**2) : -0.53000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.303 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.122 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.068 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.630 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 786 ; 0.016 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 662 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1066 ; 1.490 ; 1.963 REMARK 3 BOND ANGLES OTHERS (DEGREES): 1530 ; 0.818 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 96 ; 7.161 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 38 ;36.886 ;23.684 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 118 ;12.433 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 4 ; 8.130 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 110 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 894 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 174 ; 0.004 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 157 ; 0.216 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 653 ; 0.173 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 367 ; 0.193 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 405 ; 0.084 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 26 ; 0.198 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 10 ; 0.234 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 26 ; 0.179 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 9 ; 0.179 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 609 ; 1.822 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 756 ; 2.232 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 360 ; 3.616 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 310 ; 4.325 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. RESIDUES B21-B24 OCCUPY TWO DISTINCT REMARK 3 CONFORMATION IN EACH OF THE TWO MOLECULES IN THE ASYMMETRIC REMARK 3 UNIT. THIS ENTRY CONTAINS ATOMS WITH ZERO OCCUPANCY FOR WHICH REMARK 3 THE B-FACTORS HAVE BEEN FIXED AT 20.00. REMARK 4 REMARK 4 2CEU COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-FEB-06. REMARK 100 THE PDBE ID CODE IS EBI-27680. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-FEB-02 REMARK 200 TEMPERATURE (KELVIN) : 120.0 REMARK 200 PH : 2.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93300 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9014 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.830 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 31.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.07000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 17.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 2-ZINC INSULIN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.2 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 % ACETIC ACID, 0.05 M SODIUM REMARK 280 SULPHATE, PH 2 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 29.07600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 29.08700 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 27.39850 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 29.07600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 29.08700 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 27.39850 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 29.07600 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 29.08700 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 27.39850 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 29.07600 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 29.08700 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 27.39850 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 S SO4 A 123 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 DECREASES BLOOD GLUCOSE CONCENTRATION REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE B 1 REMARK 465 PHE D 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY B 23 PHE B 24 -149.78 REMARK 500 GLY D 23 PHE D 24 -149.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 122 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 123 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 122 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A7F RELATED DB: PDB REMARK 900 INSULIN MUTANT B16 GLU, B24 GLY, DES-B30 REMARK 900 , NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1AI0 RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (NON-SYMMETRIC), REMARK 900 NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REMARK 900 10 STRUCTURES REMARK 900 RELATED ID: 1B9E RELATED DB: PDB REMARK 900 HUMAN INSULIN MUTANT SERB9GLU REMARK 900 RELATED ID: 1BEN RELATED DB: PDB REMARK 900 INSULIN COMPLEXED WITH 4-HYDROXYBENZAMIDE REMARK 900 RELATED ID: 1EFE RELATED DB: PDB REMARK 900 AN ACTIVE MINI-PROINSULIN, M2PI REMARK 900 RELATED ID: 1EV3 RELATED DB: PDB REMARK 900 STRUCTURE OF THE RHOMBOHEDRAL FORM OF THE REMARK 900 M-CRESOL/INSULIN R6 HEXAMER REMARK 900 RELATED ID: 1EV6 RELATED DB: PDB REMARK 900 STRUCTURE OF THE MONOCLINIC FORM OF THE M REMARK 900 -CRESOL/INSULIN R6 HEXAMER REMARK 900 RELATED ID: 1EVR RELATED DB: PDB REMARK 900 THE STRUCTURE OF THE RESORCINOL/INSULIN R6 REMARK 900 HEXAMER REMARK 900 RELATED ID: 1FU2 RELATED DB: PDB REMARK 900 FIRST PROTEIN STRUCTURE DETERMINED FROM X- REMARK 900 RAY POWDERDIFFRACTION DATA REMARK 900 RELATED ID: 1FUB RELATED DB: PDB REMARK 900 FIRST PROTEIN STRUCTURE DETERMINED FROM X- REMARK 900 RAY POWDERDIFFRACTION DATA REMARK 900 RELATED ID: 1G7A RELATED DB: PDB REMARK 900 1.2 A STRUCTURE OF T3R3 HUMAN INSULIN AT REMARK 900 100 K REMARK 900 RELATED ID: 1G7B RELATED DB: PDB REMARK 900 1.3 A STRUCTURE OF T3R3 HUMAN INSULIN AT REMARK 900 100 K REMARK 900 RELATED ID: 1GUJ RELATED DB: PDB REMARK 900 INSULIN AT PH 2: STRUCTURAL ANALYSIS OF REMARK 900 THE CONDITIONS PROMOTING INSULIN FIBRE REMARK 900 FORMATION. REMARK 900 RELATED ID: 1HIQ RELATED DB: PDB REMARK 900 INSULIN (HUMAN) MUTANT WITH PHE B 24 REMARK 900 REPLACED BY SER (F24S) (NMR, REPRESENTATIVE REMARK 900 PLUS 9 STRUCTURES) REMARK 900 RELATED ID: 1HIS RELATED DB: PDB REMARK 900 INSULIN (HUMAN, DES-PENTAPEPTIDE (B 26 - B REMARK 900 30)) (NMR, REPRESENTATIVE PLUS 14 STRUCTURES) REMARK 900 RELATED ID: 1HIT RELATED DB: PDB REMARK 900 INSULIN (HUMAN) MUTANT WITH PHE B 24 REMARK 900 REPLACED BY GLY (F24G) (NMR, REPRESENTATIVE REMARK 900 PLUS 8 STRUCTURES) REMARK 900 RELATED ID: 1HLS RELATED DB: PDB REMARK 900 NMR STRUCTURE OF THE HUMAN INSULIN-HIS(B16 REMARK 900 ) REMARK 900 RELATED ID: 1HTV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DESTRIPEPTIDE (B28-B30) REMARK 900 INSULIN REMARK 900 RELATED ID: 1HUI RELATED DB: PDB REMARK 900 INSULIN MUTANT (B1, B10, B16, B27)GLU, DES REMARK 900 -B30, NMR, 25 STRUCTURES REMARK 900 RELATED ID: 1IOG RELATED DB: PDB REMARK 900 INSULIN MUTANT A3 GLY,(B1, B10, B16, B27) REMARK 900 GLU, DES-B30, NMR, 19 STRUCTURES REMARK 900 RELATED ID: 1IOH RELATED DB: PDB REMARK 900 INSULIN MUTANT A8 HIS,(B1, B10, B16, B27) REMARK 900 GLU, DES-B30, NMR, 26 STRUCTURES REMARK 900 RELATED ID: 1J73 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN UNSTABLE INSULIN REMARK 900 ANALOG WITH NATIVEACTIVITY. REMARK 900 RELATED ID: 1JCA RELATED DB: PDB REMARK 900 NON-STANDARD DESIGN OF UNSTABLE INSULIN REMARK 900 ANALOGUES WITHENHANCED ACTIVITY REMARK 900 RELATED ID: 1JCO RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE MONOMERIC [THR(B27 REMARK 900 )->PRO,PRO(B28)->THR] INSULIN MUTANT (PT REMARK 900 INSULIN) REMARK 900 RELATED ID: 1K3M RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- REMARK 900 A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS- REMARK 900 B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1KMF RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- REMARK 900 A2-ALLO-ILE, HIS-B10-ASP, PRO-B28-LYS, REMARK 900 LYS-B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1LKQ RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE- REMARK 900 A2-GLY, VAL-A3-GLY, HIS-B10-ASP, PRO- REMARK 900 B28-LYS, LYS-B29-PRO, 20 STRUCTURES REMARK 900 RELATED ID: 1LNP RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- REMARK 900 B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 20 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1LPH RELATED DB: PDB REMARK 900 LYS(B28)PRO(B29)-HUMAN INSULIN REMARK 900 RELATED ID: 1MHI RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; REMARK 900 ENGINEERED: YES MUTATION: S(B 9)D; REMARK 900 RELATED ID: 1MHJ RELATED DB: PDB REMARK 900 MOL_ID: 1; MOLECULE: INSULIN; CHAIN: A, B; REMARK 900 ENGINEERED: YES MUTATION: DES-[PHE(B 25)]; REMARK 900 RELATED ID: 1MSO RELATED DB: PDB REMARK 900 T6 HUMAN INSULIN AT 1.0 A RESOLUTION REMARK 900 RELATED ID: 1OS3 RELATED DB: PDB REMARK 900 DEHYDRATED T6 HUMAN INSULIN AT 100 K REMARK 900 RELATED ID: 1OS4 RELATED DB: PDB REMARK 900 DEHYDRATED T6 HUMAN INSULIN AT 295 K REMARK 900 RELATED ID: 1Q4V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ALLO-ILEA2-INSULIN, AN REMARK 900 INACTIVE CHIRALANALOGUE: IMPLICATIONS FOR THE REMARK 900 MECHANISM OF RECEPTOR REMARK 900 RELATED ID: 1QIY RELATED DB: PDB REMARK 900 HUMAN INSULIN HEXAMERS WITH CHAIN B HIS REMARK 900 MUTATED TO TYR COMPLEXED WITH PHENOL REMARK 900 RELATED ID: 1QIZ RELATED DB: PDB REMARK 900 HUMAN INSULIN HEXAMERS WITH CHAIN B HIS REMARK 900 MUTATED TO TYR COMPLEXED WITH RESORCINOL REMARK 900 RELATED ID: 1QJ0 RELATED DB: PDB REMARK 900 HUMAN INSULIN HEXAMERS WITH CHAIN B HIS REMARK 900 MUTATED TO TYR REMARK 900 RELATED ID: 1RWE RELATED DB: PDB REMARK 900 ENHANCING THE ACTIVITY OF INSULIN AT REMARK 900 RECEPTOR EDGE: CRYSTALSTRUCTURE AND PHOTO- REMARK 900 CROSS-LINKING OF A8 ANALOGUES REMARK 900 RELATED ID: 1SF1 RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN UNDER REMARK 900 AMYLOIDOGENICCONDITION, 15 STRUCTURES REMARK 900 RELATED ID: 1SJT RELATED DB: PDB REMARK 900 MINI-PROINSULIN, TWO CHAIN INSULIN ANALOG REMARK 900 MUTANT: DES B30, HIS(B 10)ASP, PRO(B REMARK 900 28)ASP, NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1SJU RELATED DB: PDB REMARK 900 MINI-PROINSULIN, SINGLE CHAIN INSULIN ANALOG REMARK 900 MUTANT: DES B30, HIS(B 10)ASP, PRO(B REMARK 900 28)ASP AND PEPTIDE BOND BETWEEN LYS B 29 REMARK 900 AND GLY A 1, NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1T0C RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HUMAN PROINSULIN C- REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1T1K RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- REMARK 900 B10-ASP, VAL-B12-ALA, PRO-B28-LYS, LYS- REMARK 900 B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1T1P RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- REMARK 900 B10-ASP, VAL-B12-THR, PRO-B28-LYS, LYS- REMARK 900 B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1T1Q RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN MUTANT HIS- REMARK 900 B10-ASP, VAL-B12-ABA, PRO-B28-LYS, LYS- REMARK 900 B29-PRO, 15 STRUCTURES REMARK 900 RELATED ID: 1TRZ RELATED DB: PDB REMARK 900 INSULIN (T3R3) COMPLEX WITH TWO ZINC IONS REMARK 900 RELATED ID: 1TYL RELATED DB: PDB REMARK 900 INSULIN (T3R3) (PH 6.4, 0.75 M NACL) REMARK 900 COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( REMARK 900 4'-HYDROXYACETANILIDE) REMARK 900 RELATED ID: 1TYM RELATED DB: PDB REMARK 900 INSULIN (T3R3) (PH 5.6, 1.0 M NACL) REMARK 900 COMPLEXED WITH TWO ZINC IONS AND TYLENOL ( REMARK 900 4'-HYDROXYACETANILIDE) REMARK 900 RELATED ID: 1UZ9 RELATED DB: PDB REMARK 900 CRYSTALLOGRAPHIC AND SOLUTION STUDIES OF N- REMARK 900 LITHOCHOLYL INSULIN: A NEW GENERATION OF REMARK 900 PROLONGED-ACTING INSULINS. REMARK 900 RELATED ID: 1VKT RELATED DB: PDB REMARK 900 HUMAN INSULIN TWO DISULFIDE MODEL, NMR, 10 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1W8P RELATED DB: PDB REMARK 900 STRUCTURAL PROPERTIES OF THE B25TYR-NME- REMARK 900 B26PHE INSULIN MUTANT. REMARK 900 RELATED ID: 1XDA RELATED DB: PDB REMARK 900 STRUCTURE OF INSULIN REMARK 900 RELATED ID: 1XGL RELATED DB: PDB REMARK 900 HUMAN INSULIN DISULFIDE ISOMER, NMR, 10 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1XW7 RELATED DB: PDB REMARK 900 DIABETES-ASSOCIATED MUTATIONS IN HUMAN INSULIN REMARK 900 : CRYSTALSTRUCTURE AND PHOTO-CROSS-LINKING REMARK 900 STUDIES OF A-CHAINVARIANT INSULIN WAKAYAMA REMARK 900 RELATED ID: 1ZEG RELATED DB: PDB REMARK 900 STRUCTURE OF B28 ASP INSULIN IN COMPLEX REMARK 900 WITH PHENOL REMARK 900 RELATED ID: 1ZEH RELATED DB: PDB REMARK 900 STRUCTURE OF INSULIN REMARK 900 RELATED ID: 1ZNJ RELATED DB: PDB REMARK 900 INSULIN, MONOCLINIC CRYSTAL FORM REMARK 900 RELATED ID: 2AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REMARK 900 20 STRUCTURES REMARK 900 RELATED ID: 2C8Q RELATED DB: PDB REMARK 900 INSULINE(1SEC) AND UV LASER EXCITED REMARK 900 FLUORESCENCE REMARK 900 RELATED ID: 2C8R RELATED DB: PDB REMARK 900 INSULINE(60SEC) AND UV LASER EXCITED REMARK 900 FLUORESCENCE REMARK 900 RELATED ID: 2HIU RELATED DB: PDB REMARK 900 NMR STRUCTURE OF HUMAN INSULIN IN 20% REMARK 900 ACETIC ACID, ZINC-FREE, 10 STRUCTURES REMARK 900 RELATED ID: 3AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, REMARK 900 REFINED AVERAGE STRUCTURE REMARK 900 RELATED ID: 4AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' REMARK 900 GREEN' SUBSTATE, AVERAGE STRUCTURE REMARK 900 RELATED ID: 5AIY RELATED DB: PDB REMARK 900 R6 HUMAN INSULIN HEXAMER (SYMMETRIC), NMR, ' REMARK 900 RED' SUBSTATE, AVERAGE STRUCTURE DBREF 2CEU A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2CEU B 1 25 UNP P01308 INS_HUMAN 25 49 DBREF 2CEU C 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2CEU D 1 25 UNP P01308 INS_HUMAN 25 49 SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 25 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 25 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE SEQRES 1 C 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 C 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 D 25 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 D 25 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE HET SO4 A 122 5 HET SO4 A 123 5 HET SO4 C 122 5 HETNAM SO4 SULFATE ION FORMUL 5 SO4 3(O4 S 2-) FORMUL 8 HOH *65(H2 O1) HELIX 1 1 GLY A 1 CYS A 7 1 7 HELIX 2 2 SER A 12 ASN A 18 1 7 HELIX 3 3 CYS B 7 GLY B 20 1 14 HELIX 4 4 GLY C 1 CYS C 7 1 7 HELIX 5 5 SER C 12 ASN C 18 1 7 HELIX 6 6 GLY D 8 GLY D 20 1 13 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.08 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.10 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.01 SSBOND 4 CYS C 6 CYS C 11 1555 1555 2.08 SSBOND 5 CYS C 7 CYS D 7 1555 1555 2.10 SSBOND 6 CYS C 20 CYS D 19 1555 1555 2.01 SITE 1 AC1 7 GLY A 1 ILE A 2 VAL A 3 GLU A 4 SITE 2 AC1 7 HOH A2023 GLY C 1 TYR C 19 SITE 1 AC2 3 HOH A2021 HOH A2022 HOH A2023 SITE 1 AC3 8 GLY A 1 TYR A 19 HOH A2022 GLY C 1 SITE 2 AC3 8 ILE C 2 VAL C 3 GLU C 4 HOH C2018 CRYST1 58.152 58.174 54.797 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017196 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017190 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018249 0.00000 MTRIX1 1 -0.000430 -1.000000 -0.000550 29.09974 1 MTRIX2 1 -1.000000 0.000430 0.000370 29.06617 1 MTRIX3 1 -0.000370 0.000550 -1.000000 27.39189 1